Kaiser’s Michael Robkin Tackles Interoperability

By Cindy Atoji

Jan. 8, 2008 | Achieving interoperability isn’t cheap. For every $1 million spent on equipment, integration can cost another $300,000 to $400,000, according to a Kaiser Permanente study. In fact, according to Michael Robkin of Kaiser, “All of our business decisions related to system acquisition and deployment take into account interoperability. No aspect of health care operates in a silo anymore.”

Robkin is principal enterprise architect in care delivery for Kaiser Permanente Information technology, the $1 billion technology management arm of the Kaiser Foundation Hospitals. He is responsible for Kaiser Permanente’s national systems strategy for pharmacy, biomedical devices, and medical imaging. Robkin is also treasurer of Continua Health Alliance, an industry alliance dedicated to establishing a system of interoperable personal telehealth solutions. Digital HealthCare & Productivity spoke with Robkin about the growing importance of interoperability in the paradigm of providing health care.

DHP: Interoperability has become a ubiquitous buzzword for health care delivery systems. But, let’s get to the bottom line. How can interoperability provide good ROI?

Robkin: Interoperability provides ROI in a few ways. First, it reduces acquisition costs. Examples vary, but we usually find that integration of a new system can easily be between 10 and 50 percent of the total system cost. So the ability to use off-the-shelf interfaces and support saves a lot of money at implementation.

It also saves money over the long run since a standard interface will be easier to maintain. Interoperability also enables the user to switch out obsolete equipment. This provides value to the owner since there are lower replacement costs, and also to the vendor since it will be easier to keep customers’ systems on the most current software version. We have found that as our systems age it eventually becomes just as expensive to replace them entirely than to upgrade them.

There are user savings that are harder to quantify. If all users have the same user interface then things like training are obviously cheaper. There is also some value that can only be realized through some level of interoperability. For example: sharing data to create data warehouses [which provides] an opportunity to find value in the data. [Doing that] may not be cost effective without interoperability.

DHP: How can health care systems drive down the cost of ownership for interoperability and system scalability?

Robkin: There’s no need to drive down the cost of interoperability. We believe that an interoperable system costs the same as as a proprietary system, in fact, the total cost of ownership is much lower, you just need the organizational desire and will to buy interoperable systems and demand them from vendors.

System scability is a well-known software engineering problem — it’s not rocket science but there’re lot of lessons in terms of software engineering and support from other industries that health care could learn from. We’re so focused on capability and functional aspects of the systems that we’ve fallen behind in best practices as far as acquiring, maintaining, developing, and supporting, technology.

In requirements analysis, for example, it’s easy to get providers to talk about what they want, but sometimes it’s a bit of challenge to narrow that down and prioritize. Care providers understand the need for functions to provide better care for patients, but it’s difficult to think about what’s most important. People work in different ways, and if they just ask for systems that duplicate your current processes, then you lose the chance to rationalize and standardize processes, which is the first step that’s necessary before you standardize a system.

DHP: You’ve said that organizations shouldn’t stress collecting data that no one uses or pay for accuracy you don’t need. How can this be avoided?

Robkin: We need to look at value of information and what it will be used for and not pay for accuracy we don’t need. But there’s sometimes a danger from the technology side, of over-engineering and collecting more data than is needed.

I think the low hanging fruit in health care IT is in the integration of the data -- taking disparate data sets and connecting them; correlating them and putting them in data warehouses so we can do research. That low hanging fruit doesn’t require any more detail than care providers need, and often it means less detail. But combining data sets has been difficult to achieve in health care because of lack of interoperability and lack of standardization around the data. That’s where the next value will come from in health care IT-- an excess of data precision and accuracy is not necessary.

DHP: Various groups have collected a many “use cases” and requirements. What can we do with these to make progress toward interoperability?

Robkin: The old use cases were very particular about functions. I think the use cases we’re getting now are broader, and are more about how to treat a whole disease or entire clinical process, but I still don’t think they’re broad enough. The industry needs to develop complete use cases for entire treatments and then use these in their standards organizations and in their product acquisitions to create standards that support not just a particular function but that support the entire process for treating a particular disease. When we have a complete set of use cases for the industry, they’ll be used by the standards groups, government, and vendors to create comprehensive systems that support all the functions we need and create standards that will allow us to interoperate at a higher level.

DHP: What does 2008 hold as far as progress in interoperability?

Robkin: I think we’ll see more progress than in previous years. I think as the industry rolls out more electronic health records, there will be a growing demand to connect medical devices to the EHRs. Care providers, having made a big investment in EHRs, are going to start looking around and seeing that all of these other devices and systems that have very useful data for the EHR. At that point they’ll start to recognize the need for standardization and interoperability and their users will understand it as well.

Want to read more expert articles like this? Click here to subscribe to Digital HealthCare & Productivity.

White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .